DMD CLINICAL THERAPIES I P.119Tamoxifen in Duchenne muscular dystrophy: rationale and protocol for a multicentre, randomised, double-blind, placebo-controlled, phase 3 safety and efficacy 48-week trial
Neuromuscular Disorders（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要